1 / 14

U.S. Intravenous Solutions Market Analysis (2019-2027)

Read here the market research report on the u201cU.S. Intravenous Solutions Market" published by CMI Team

kunalbhuta
Download Presentation

U.S. Intravenous Solutions Market Analysis (2019-2027)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. U.S. INTRAVENOUS SOLUTION MARKET ANALYSIS (2019-2027) • U.S. Intravenous Solutions Market, By Solution Type (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. U.S. Intravenous Solutions Market – Insights • Intravenous solutions (IV) are administered to patients to transfer sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. Adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio of intravenous solutions is expected to drive growth of the U.S. intravenous solutions market. For instance, in April 2015, Baxter International Inc. and France-based LaboratoireAguettant SAS, entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.

  4. U.S. intravenous solutions market size was estimated to be valued at US$ 2,665.5 million in 2019 and is expected to witness a CAGR of 6.4% over the forecast period (2019 – 2027).

  5. U.S. Intravenous Solutions Market Share (%) Analysis, By Solution Type, 2019

  6. Increasing Launches and Regulatory Approvals of Intravenous Solution Injections is expected to Drive Growth of the US Intravenous Solutions Market • Increasing approvals of intravenous solution injections from regulatory authorities are expected to drive the U.S. intravenous solution market growth over the forecast period. In July 2019, Baxter International Inc. announced that the US Food and Drug Administration (FDA) approved its Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection). Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection) is the first and only ready-to-use insulin for IV infusion in hospitals and other acute care settings.

  7. Furthermore, in January 2018, Baxter International Inc. announced that the US Food and Drug Administration (FDA) approved its Bivalirudin in 0.9% Sodium Chloride Injection (Bivalirudin). Bivalirudin is a specific and direct thrombin inhibitor indicated as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), a common non-surgical procedure to treat blocked or narrowed blood vessels in the heart. • Launches of new intravenous solution injections for treatment of various diseases such as dehydration, gastrointestinal diseases are expected to boost the market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, provider of medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.

  8. U.S. Intravenous Solutions Market - Restraints • Growth of the U.S. intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.

  9. US Intravenous Solutions Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2027

  10. U.S. Intravenous Solutions Market - Competitive Landscape • Key players operating in the U.S Intravenous Solution Market include Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen Ag and Grifols, S.A.

  11. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/us-intravenous-solution-market-3400

  12. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  13. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  14. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related